TY  - GEN
AU  - Scirica,Benjamin M
AU  - Belardinelli,Luiz
AU  - Chaitman,Bernard R
AU  - Waks,Jonathan W
AU  - Volo,Samuel
AU  - Karwatowska-Prokopczuk,Ewa
AU  - Murphy,Sabina A
AU  - Cheng,Mei L
AU  - Braunwald,Eugene
AU  - Morrow,David A
TI  - Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial
SN  - 1532-2092
PY  - 2015///0908
KW  - Acetanilides
KW  - administration & dosage
KW  - Acute Coronary Syndrome
KW  - drug therapy
KW  - Age Distribution
KW  - Aged
KW  - Aged, 80 and over
KW  - Atrial Fibrillation
KW  - Comorbidity
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Longitudinal Studies
KW  - Male
KW  - Massachusetts
KW  - epidemiology
KW  - Piperazines
KW  - Placebo Effect
KW  - Prevalence
KW  - Ranolazine
KW  - Risk Factors
KW  - Sodium Channel Blockers
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/europace/euu217
ER  -